160 related articles for article (PubMed ID: 18463958)
1. 5-Fluorouracil incorporated into the tissue RNA of human and rat bladder carcinoma after administration of 1-(2-tetrahydrofuryl)-5-fluorouracil combined with uracil.
Tsujimoto S; Fujimoto K; Okajima E; Ozono S; Okajima E; Hirao Y
Int J Clin Oncol; 2008 Apr; 13(2):138-43. PubMed ID: 18463958
[TBL] [Abstract][Full Text] [Related]
2. [Effect of UFT on urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine].
Samma S; Tabata S; Nakatsuji F; Yoshie T; Moriya A; Matsuki H; Watanabe S; Babaya K; Hirao Y; Okajima E
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1661-8. PubMed ID: 3927848
[TBL] [Abstract][Full Text] [Related]
3. [Level of inhibition of thymidylate synthase activity and 5-fluorouracil in tumor tissues after administration of UFT or tegafur].
Suzuki M; Sekiguchi I; Tamada T; Nishida M
Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1399-404. PubMed ID: 2530293
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between tissue concentrations of 5-FU and degeneration of tissues after UFT administration in patients with bladder tumor].
Takeyama M; Honjoh M; Ohnishi N; Ishikawa Y; Sakaguchi H; Hanai J
Gan To Kagaku Ryoho; 1993 Oct; 20(13):1953-9. PubMed ID: 8215468
[TBL] [Abstract][Full Text] [Related]
5. Superior antitumour activity of S-1 in tumours with a high dihydropyrimidine dehydrogenase activity.
Fujiwara H; Terashima M; Irinoda T; Takagane A; Abe K; Nakaya T; Yonezawa H; Oyama K; Takahashi M; Saito K; Takechi T; Fukushima M; Shirasaka T
Eur J Cancer; 2003 Nov; 39(16):2387-94. PubMed ID: 14556932
[TBL] [Abstract][Full Text] [Related]
6. [Studies on 5-FU concentration in serum and bladder tumor tissue after oral administration of UFT].
Takayama H; Konami T; Konishi T; Pak K; Tomoyoshi T
Hinyokika Kiyo; 1986 Oct; 32(10):1449-53. PubMed ID: 3105272
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity and low intestinal toxicity of S-1, a new formulation of oral tegafur, in experimental tumor models in rats.
Takechi T; Nakano K; Uchida J; Mita A; Toko K; Takeda S; Unemi N; Shirasaka T
Cancer Chemother Pharmacol; 1997; 39(3):205-11. PubMed ID: 8996521
[TBL] [Abstract][Full Text] [Related]
8. [Thymidylate synthase inhibition and concentration of 5-fluorouracil after administration of UFT in human uroepithelial carcinomas].
Kanimoto Y; Suzuki Y; Miwa Y; Akino H; Isomatu Y; Okada K
Hinyokika Kiyo; 1991 Mar; 37(3):229-33. PubMed ID: 1648873
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant effects of calmodulin antagonists on antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (ftorafur) and a mixture of ftorafur and uracil (UFT) in nude mice bearing human ovarian carcinomas.
Kikuchi Y; Oomori K; Iwano I; Kizawa I; Miyauchi M; Kita T; Kuki E
Gynecol Oncol; 1989 Nov; 35(2):172-6. PubMed ID: 2509301
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil and UFT-sensitive gastric carcinoma has a high level of thymidylate synthase.
Maehara Y; Kusumoto T; Kusumoto H; Anai H; Sakaguchi Y; Kido Y; Okamura T; Korenaga D; Sugimachi K
Cancer; 1989 May; 63(9):1693-6. PubMed ID: 2495166
[TBL] [Abstract][Full Text] [Related]
11. Relationship of in vivo antitumor activities of fluorinated pyrimidines to thymidylate synthase activity and intratumoral concentrations of 5-fluorouracil and uracil.
Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Imai S; Tobe T
Anticancer Res; 1991; 11(2):607-12. PubMed ID: 2064315
[TBL] [Abstract][Full Text] [Related]
12. Studies on the metabolism of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil co-administered orally to tumor-bearing rats.
Kawaguchi Y; Nagayama S; Masuda H; Yasuda A
Gan; 1980 Dec; 71(6):889-99. PubMed ID: 6791982
[TBL] [Abstract][Full Text] [Related]
13. [5-Fluorouracil, tegafur, and uracil concentrations in serum and tissue of the patients with hepatocellular carcinoma after UFT administration].
Suenaga M
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3313-8. PubMed ID: 2825604
[TBL] [Abstract][Full Text] [Related]
14. [Level of 5-FU in cancerous and normal tissues of nude mice after oral administration of tegafur coadministered with uracil (UFT)].
Sekiguchi I; Suzuki M; Tamada T; Nishida M
Gan To Kagaku Ryoho; 1985 May; 12(5):1094-8. PubMed ID: 3922312
[TBL] [Abstract][Full Text] [Related]
15. Clinical basis of chemotherapy for gastric cancer with uracil and 1-(2'-tetrahydrofuryl)-5-fluorouracil.
Kimura K; Suga S; Shimaji T; Kitamura M; Kubo K; Suzuoki Y; Isobe K
Gastroenterol Jpn; 1980; 15(4):324-9. PubMed ID: 6773844
[TBL] [Abstract][Full Text] [Related]
16. Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial.
Ishizuka M; Kubota K; Nemoto T; Shimoda M; Kato M; Iso Y; Tago K
Asian J Surg; 2016 Jul; 39(3):149-54. PubMed ID: 26123137
[TBL] [Abstract][Full Text] [Related]
17. Effects of the anticancer drug cocktail "UFT" on metastatic potentials of squamous cell carcinoma (O-1N) in a hamster model.
Naito Y; Kimura S; Yoshizawa M; Ohtake K; Nakajima T; Saku T
Oral Oncol; 1998 Sep; 34(5):326-31. PubMed ID: 9861336
[TBL] [Abstract][Full Text] [Related]
18. [Experimental model of urinary bladder tumor in rats for evaluation of chemotherapeutic agents].
Hirao Y; Momose H; Samma S; Ozono S; Babaya K; Okajima E
Hinyokika Kiyo; 1988 Nov; 34(11):1885-93. PubMed ID: 3242363
[TBL] [Abstract][Full Text] [Related]
19. Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine.
Ooi A; Ohkubo T; Higashigawa M; Kawasaki H; Kakito H; Kagawa Y; Kojima M; Sakurai M
Biol Pharm Bull; 2001 Nov; 24(11):1329-31. PubMed ID: 11725974
[TBL] [Abstract][Full Text] [Related]
20. [5-FU concentration in blood and tissue of patients with renal cell carcinoma after administration of UFT].
Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
Gan To Kagaku Ryoho; 1985 Feb; 12(2):320-4. PubMed ID: 3918507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
